Heres a quick look at the most common side effects for each medication, as reported by at least 5% of people in clinical trials: For some people, these side effects can become disruptive, leading them to seek an alternative medication
For questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call the Sanofi Insulins Co-pay Savings Program at (866) 255-8661 (866) 255-8661 (9:00 am-7:00 pm EST, Monday-Friday)
Dispose of expired material per local chemical and biological waste regulations
Rybelsus (semaglutide) Tablets, 3 mg, offer a groundbreaking oral treatment option for adults with type 2 diabetes
Magnesium supplements support muscle relaxation and prevent cramping during the rehabilitation period
Understanding GLP-1 Agonists GLP-1 agonists are a key part of this new wave